Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anuradha Bhattacharyya

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|July 17, 2007
Mining the GEMS--a novel platform technology targeting post-transcriptional control mechanismsAnuradha Bhattacharyya, Christopher R Trotta, Stuart W Peltz
Drug Discovery Today|November 10, 2022
Targeting strategies for modulating pre-mRNA splicing with small molecules: Recent advancesScott J Barraza, Anuradha Bhattacharyya, Christopher R Trotta, et al.
British Journal of Clinical Pharmacology|August 18, 2024
Pharmacokinetics and pharmacodynamics of PTC518, an oral huntingtin lowering splicing modifier: A first-in-human studyLan Gao, Anuradha Bhattacharyya, Brian Beers, et al.
Plos One|September 10, 2011
Utility of survival motor neuron ELISA for spinal muscular atrophy clinical and preclinical analysesDione T Kobayashi, Rory J Olson, Laurel Sly, et al.
Nature Communications|December 16, 2021
Small molecule splicing modifiers with systemic HTT-lowering activityAnuradha Bhattacharyya, Christopher R Trotta, Jana Narasimhan, et al.
Science (New York, N.Y.)|August 9, 2014
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophyNikolai A Naryshkin, Marla Weetall, Amal Dakka, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|July 17, 2007
Mining the GEMS--a novel platform technology targeting post-transcriptional control mechanismsAnuradha Bhattacharyya, Christopher R Trotta, Stuart W Peltz
Drug Discovery Today|November 10, 2022
Targeting strategies for modulating pre-mRNA splicing with small molecules: Recent advancesScott J Barraza, Anuradha Bhattacharyya, Christopher R Trotta, et al.
British Journal of Clinical Pharmacology|August 18, 2024
Pharmacokinetics and pharmacodynamics of PTC518, an oral huntingtin lowering splicing modifier: A first-in-human studyLan Gao, Anuradha Bhattacharyya, Brian Beers, et al.
Plos One|September 10, 2011
Utility of survival motor neuron ELISA for spinal muscular atrophy clinical and preclinical analysesDione T Kobayashi, Rory J Olson, Laurel Sly, et al.
Nature Communications|December 16, 2021
Small molecule splicing modifiers with systemic HTT-lowering activityAnuradha Bhattacharyya, Christopher R Trotta, Jana Narasimhan, et al.
Science (New York, N.Y.)|August 9, 2014
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophyNikolai A Naryshkin, Marla Weetall, Amal Dakka, et al.
Pageof 1